-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2011 to 2022.
- Invivo Therapeutics Holdings Corp. Earnings Per Share, Diluted for the quarter ending March 31, 2023 was -0.85 USD/shares, a 56.2% increase year-over-year.
- Invivo Therapeutics Holdings Corp. Earnings Per Share, Diluted for the twelve months ending March 31, 2023 was -5.74 USD/shares, a 23.8% increase year-over-year.
- Invivo Therapeutics Holdings Corp. annual Earnings Per Share, Diluted for 2022 was -6.83 USD/shares, a 8.69% increase from 2021.
- Invivo Therapeutics Holdings Corp. annual Earnings Per Share, Diluted for 2021 was -7.48 USD/shares, a 471% decline from 2020.
- Invivo Therapeutics Holdings Corp. annual Earnings Per Share, Diluted for 2020 was -1.31 USD/shares.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)